GW Pharmaceuticals was founded in 1998 and is listed on both the NASDAQ Global Market (GWPH) and AIM, a market of the London Stock read more
Jeff Krol — Vice President Market Access and Payer Strategy at GW Pharmaceuticals
Executive Bio
Jeff Krol serves as the Vice President Market Access and Payer Strategy of GW Pharmaceuticals. Jeff Krol and the GW Pharmaceuticals executive team are rated a D by 2 employees.
Executive Team Culture Ratings from GW Pharmaceuticals Employees
BOTTOM
15%
GW Pharmaceuticals' Executive Team scores in the Bottom 15%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at GW PharmaceuticalsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at GW PharmaceuticalsGW Pharmaceuticals' Executive Team at a Glance
Based on 3 ratings, GW Pharmaceuticals' employees are less satisfied with their Executive Team and give them a “D” or 53/100.
GW Pharmaceuticals' Executive Team ranks in the Bottom 15% of other companies on Comparably that also have 201-500 Employees.
×